Bill Nygren’s Amgen AMGN Stock Holding History

Bill Nygren’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-2,519	Closed	-$401K	–	169
2014 Q4	$401K	Sell	2,519 -518	-17%	-$80.7K	﹤0.01%	164
2014 Q3	$427K	Hold	3,037	–	–	﹤0.01%	156
2014 Q2	$359K	Sell	3,037 -18	-0.6%	-$2.08K	﹤0.01%	164
2014 Q1	$377K	Hold	3,055	–	–	﹤0.01%	166
2013 Q4	$349K	Sell	3,055 -181	-6%	-$20.6K	﹤0.01%	171
2013 Q3	$362K	Hold	3,236	–	–	﹤0.01%	166
2013 Q2	$319K	Buy	+3,236	New	+$336K	﹤0.01%	174

Other funds holding AMGN

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Bill Nygren's AMGN Position: Q1 2015 in Review

Bill Nygren sold out of Amgen (AMGN) in Q1 2015, closing a stake of 2,519 shares — an estimated $401K sold.

Bill Nygren first reported a position in AMGN in Q2 2013 and held it in 7 quarters. The position peaked at $427K in Q3 2014. 1,345 funds tracked by Wall St. Rank hold AMGN as of Q1 2015.

Bill Nygren reported no remaining Amgen position as of Q1 2015 after selling out during the quarter.
Bill Nygren sold 2,519 Amgen shares in Q1 2015, an estimated $401K.
Bill Nygren first reported a position in Amgen in Q2 2013 and held it in 7 quarters.
Bill Nygren's Amgen position peaked at $427K in Q3 2014.
1,345 funds tracked by Wall St. Rank held Amgen as of Q1 2015.

Based on Harris Associates's 13F filing for Q1 2015, filed 14 May 2015.